AstraZeneca’s vaccine gets UK approval, but the FDA has yet to decide. Bill Barker analyzes that story, reacts to 2021 precitions about the price of oil and a return to domestic travel, and shares why future investors might not realize how crazy 2020 was for the stock market.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
